Genomic Sequencing Surveillance and Antigenic Site Mutations of Respiratory Syncytial Virus in Arizona, USA

LaRinda A. Holland,Steven C. Holland,Matthew F. Smith,Victoria R. Leonard,Vel Murugan,Lora Nordstrom,Mary Mulrow,Raquel Salgado,Michael White,Efrem S. Lim
DOI: https://doi.org/10.1101/2023.06.16.23291299
2023-06-20
Abstract:Abstract We conducted Respiratory Syncytial Virus (RSV) genomic sequencing surveillance of 100 RSV-A and 27 RSV-B specimens collected between November 2022 and April 2023 in Arizona, USA. We identified mutations in the pre-fusion F protein antigenic sites in both RSV-A and RSV-B. Continued genomic surveillance will be important to ensure RSV vaccine effectiveness.
What problem does this paper attempt to address?